(SYM) Symbotic - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US87151X1019
Stock: Warehouse Automation, Robotics, Software, Integration, Supply Chain
Total Rating 48
Risk 44
Buy Signal -2.02
| Risk 5d forecast | |
|---|---|
| Volatility | 83.0% |
| Relative Tail Risk | -10.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.26 |
| Alpha | 77.67 |
| Character TTM | |
|---|---|
| Beta | 2.672 |
| Beta Downside | 2.767 |
| Drawdowns 3y | |
|---|---|
| Max DD | 72.46% |
| CAGR/Max DD | 0.56 |
EPS (Earnings per Share)
Revenue
Risks
Technicals:
volatile
Description: SYM Symbotic March 04, 2026
Symbotic Inc. (NASDAQ: SYM) is an automation technology company based in Wilmington, Massachusetts.
The company specializes in warehouse automation, developing technologies to improve operational efficiency. This includes automating the handling of pallets, cases, and individual items. Warehouse automation is a growing sector, driven by increasing e-commerce demand and labor shortages.
Symbotics systems focus on enhancing supply chain front-end operations. This business model offers robotics-as-a-service or direct sales of integrated automation solutions.
For more detailed financial analysis, consider exploring ValueRay.
Headlines to watch out for
- Warehouse automation demand fuels recurring revenue growth
- Robotics and AI innovation drives competitive advantage
- Supply chain disruptions increase automation adoption
- Large enterprise partnerships secure significant revenue streams
- Labor shortages accelerate warehouse automation investments
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: -10.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.26 > 0.02 and ΔFCF/TA 18.56 > 1.0 |
| NWC/Revenue: 28.22% < 20% (prev 13.66%; Δ 14.56% < -1%) |
| CFO/TA 0.29 > 3% & CFO 853.5m > Net Income -10.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.38 > 1.5 & < 3 |
| Outstanding Shares: last quarter (127.9m) vs 12m ago 20.52% < -2% |
| Gross Margin: 19.21% > 18% (prev 0.15%; Δ 1906 % > 0.5%) |
| Asset Turnover: 101.5% > 50% (prev 111.6%; Δ -10.12% > 0%) |
| Interest Coverage Ratio: -12.58 > 6 (EBITDA TTM -8.90m / Interest Expense TTM 4.44m) |
Altman Z'' -0.82
| A: 0.23 (Total Current Assets 2.46b - Total Current Liabilities 1.78b) / Total Assets 2.99b |
| B: -0.44 (Retained Earnings -1.33b / Total Assets 2.99b) |
| C: -0.02 (EBIT TTM -55.9m / Avg Total Assets 2.35b) |
| D: -0.66 (Book Value of Equity -1.33b / Total Liabilities 2.03b) |
| Altman-Z'' Score: -0.82 = CCC |
Beneish M -3.14
| DSRI: 0.80 (Receivables 357.2m/357.7m, Revenue 2.39b/1.91b) |
| GMI: 0.80 (GM 19.21% / 15.41%) |
| AQI: 1.58 (AQ_t 0.14 / AQ_t-1 0.09) |
| SGI: 1.25 (Revenue 2.39b / 1.91b) |
| TATA: -0.29 (NI -10.9m - CFO 853.5m) / TA 2.99b) |
| Beneish M-Score: -3.14 (Cap -4..+1) = AA |
What is the price of SYM shares?
As of March 09, 2026, the stock is trading at USD 48.61 with a total of 1,854,609 shares traded.
Over the past week, the price has changed by -10.33%, over one month by -22.27%, over three months by -19.63% and over the past year by +129.62%.
Over the past week, the price has changed by -10.33%, over one month by -22.27%, over three months by -19.63% and over the past year by +129.62%.
Is SYM a buy, sell or hold?
Symbotic has received a consensus analysts rating of 3.84.
Therefore, it is recommended to buy SYM.
- StrongBuy: 8
- Buy: 2
- Hold: 8
- Sell: 0
- StrongSell: 1
What are the forecasts/targets for the SYM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 63.9 | 31.5% |
| Analysts Target Price | 63.9 | 31.5% |
SYM Fundamental Data Overview March 05, 2026
P/E Forward = 303.0303
P/S = 13.2716
P/B = 10.2702
P/EG = 10.0669
Revenue TTM = 2.39b USD
EBIT TTM = -55.9m USD
EBITDA TTM = -8.90m USD
Long Term Debt = 43.9m USD (estimated: total debt 52.0m - short term 8.07m)
Short Term Debt = 8.07m USD (from shortTermDebt, last quarter)
Debt = 52.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.77b USD (from netDebt column, last quarter)
Enterprise Value = 29.95b USD (31.72b + Debt 52.0m - CCE 1.82b)
Interest Coverage Ratio = -12.58 (Ebit TTM -55.9m / Interest Expense TTM 4.44m)
EV/FCF = 38.42x (Enterprise Value 29.95b / FCF TTM 779.7m)
FCF Yield = 2.60% (FCF TTM 779.7m / Enterprise Value 29.95b)
FCF Margin = 32.62% (FCF TTM 779.7m / Revenue TTM 2.39b)
Net Margin = -0.45% (Net Income TTM -10.9m / Revenue TTM 2.39b)
Gross Margin = 19.21% ((Revenue TTM 2.39b - Cost of Revenue TTM 1.93b) / Revenue TTM)
Gross Margin QoQ = 20.04% (prev 20.55%)
Tobins Q-Ratio = 10.00 (Enterprise Value 29.95b / Total Assets 2.99b)
Interest Expense / Debt = 219.8% (Interest Expense 114.2m / Debt 52.0m)
Taxrate = 4.40% (615.0k / 14.0m)
NOPAT = -53.4m (EBIT -55.9m * (1 - 4.40%)) [loss with tax shield]
Current Ratio = 1.38 (Total Current Assets 2.46b / Total Current Liabilities 1.78b)
Debt / Equity = 0.08 (Debt 52.0m / totalStockholderEquity, last quarter 663.8m)
Debt / EBITDA = 198.6 (negative EBITDA) (Net Debt -1.77b / EBITDA -8.90m)
Debt / FCF = -2.27 (Net Debt -1.77b / FCF TTM 779.7m)
Total Stockholder Equity = 325.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.46% (Net Income -10.9m / Total Assets 2.99b)
RoE = -3.34% (Net Income TTM -10.9m / Total Stockholder Equity 325.3m)
RoCE = -15.13% (EBIT -55.9m / Capital Employed (Equity 325.3m + L.T.Debt 43.9m))
RoIC = -16.42% (negative operating profit) (NOPAT -53.4m / Invested Capital 325.3m)
WACC = 15.73% (E(31.72b)/V(31.77b) * Re(15.76%) + (debt cost/tax rate unavailable))
Discount Rate = 15.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 23.88%
[DCF] Terminal Value 43.87% ; FCFF base≈519.2m ; Y1≈340.8m ; Y5≈155.5m
[DCF] Fair Price = 24.94 (EV 1.37b - Net Debt -1.77b = Equity 3.14b / Shares 125.8m; r=15.73% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 63.04 | EPS CAGR: 38.94% | SUE: -0.31 | # QB: 0
Revenue Correlation: 91.66 | Revenue CAGR: 65.02% | SUE: 0.29 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.12 | Chg7d=+0.000 | Chg30d=+0.002 | Revisions Net=+4 | Analysts=9
EPS current Year (2026-09-30): EPS=0.50 | Chg7d=+0.000 | Chg30d=+0.044 | Revisions Net=+5 | Growth EPS=-74.6% | Growth Revenue=+23.2%
EPS next Year (2027-09-30): EPS=0.75 | Chg7d=+0.000 | Chg30d=-0.027 | Revisions Net=+3 | Growth EPS=+49.6% | Growth Revenue=+28.9%
[Analyst] Revisions Ratio: +1.00 (4 Up / 0 Down within 30d for Next Quarter)
P/S = 13.2716
P/B = 10.2702
P/EG = 10.0669
Revenue TTM = 2.39b USD
EBIT TTM = -55.9m USD
EBITDA TTM = -8.90m USD
Long Term Debt = 43.9m USD (estimated: total debt 52.0m - short term 8.07m)
Short Term Debt = 8.07m USD (from shortTermDebt, last quarter)
Debt = 52.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -1.77b USD (from netDebt column, last quarter)
Enterprise Value = 29.95b USD (31.72b + Debt 52.0m - CCE 1.82b)
Interest Coverage Ratio = -12.58 (Ebit TTM -55.9m / Interest Expense TTM 4.44m)
EV/FCF = 38.42x (Enterprise Value 29.95b / FCF TTM 779.7m)
FCF Yield = 2.60% (FCF TTM 779.7m / Enterprise Value 29.95b)
FCF Margin = 32.62% (FCF TTM 779.7m / Revenue TTM 2.39b)
Net Margin = -0.45% (Net Income TTM -10.9m / Revenue TTM 2.39b)
Gross Margin = 19.21% ((Revenue TTM 2.39b - Cost of Revenue TTM 1.93b) / Revenue TTM)
Gross Margin QoQ = 20.04% (prev 20.55%)
Tobins Q-Ratio = 10.00 (Enterprise Value 29.95b / Total Assets 2.99b)
Interest Expense / Debt = 219.8% (Interest Expense 114.2m / Debt 52.0m)
Taxrate = 4.40% (615.0k / 14.0m)
NOPAT = -53.4m (EBIT -55.9m * (1 - 4.40%)) [loss with tax shield]
Current Ratio = 1.38 (Total Current Assets 2.46b / Total Current Liabilities 1.78b)
Debt / Equity = 0.08 (Debt 52.0m / totalStockholderEquity, last quarter 663.8m)
Debt / EBITDA = 198.6 (negative EBITDA) (Net Debt -1.77b / EBITDA -8.90m)
Debt / FCF = -2.27 (Net Debt -1.77b / FCF TTM 779.7m)
Total Stockholder Equity = 325.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -0.46% (Net Income -10.9m / Total Assets 2.99b)
RoE = -3.34% (Net Income TTM -10.9m / Total Stockholder Equity 325.3m)
RoCE = -15.13% (EBIT -55.9m / Capital Employed (Equity 325.3m + L.T.Debt 43.9m))
RoIC = -16.42% (negative operating profit) (NOPAT -53.4m / Invested Capital 325.3m)
WACC = 15.73% (E(31.72b)/V(31.77b) * Re(15.76%) + (debt cost/tax rate unavailable))
Discount Rate = 15.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 23.88%
[DCF] Terminal Value 43.87% ; FCFF base≈519.2m ; Y1≈340.8m ; Y5≈155.5m
[DCF] Fair Price = 24.94 (EV 1.37b - Net Debt -1.77b = Equity 3.14b / Shares 125.8m; r=15.73% [WACC]; 5y FCF grow -40.0% → 2.90% )
EPS Correlation: 63.04 | EPS CAGR: 38.94% | SUE: -0.31 | # QB: 0
Revenue Correlation: 91.66 | Revenue CAGR: 65.02% | SUE: 0.29 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.12 | Chg7d=+0.000 | Chg30d=+0.002 | Revisions Net=+4 | Analysts=9
EPS current Year (2026-09-30): EPS=0.50 | Chg7d=+0.000 | Chg30d=+0.044 | Revisions Net=+5 | Growth EPS=-74.6% | Growth Revenue=+23.2%
EPS next Year (2027-09-30): EPS=0.75 | Chg7d=+0.000 | Chg30d=-0.027 | Revisions Net=+3 | Growth EPS=+49.6% | Growth Revenue=+28.9%
[Analyst] Revisions Ratio: +1.00 (4 Up / 0 Down within 30d for Next Quarter)